Medicine & Life Sciences
Neurofibromatosis 1
100%
Neurofibroma
93%
Glioma
56%
Neoplasms
47%
Neurofibromatoses
45%
Schwannomatosis
41%
Skin
40%
Glioblastoma
39%
Protein-Tyrosine Kinases
30%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
28%
National Cancer Institute (U.S.)
27%
Mexico
25%
terameprocol
25%
Leukemia, Myeloid, Chronic Phase
24%
Cytogenetics
23%
Education
22%
Central Nervous System Neoplasms
22%
Therapeutics
20%
Survival
18%
Drug Therapy
15%
Isocitrate Dehydrogenase
15%
Imatinib Mesylate
14%
Medulloblastoma
14%
Clinical Trials
14%
Tumor Burden
14%
Diffusion Magnetic Resonance Imaging
14%
Brain Neoplasms
13%
Molecular Pathology
13%
Tandem Mass Spectrometry
13%
Liquid Chromatography
12%
Congresses
11%
Tertiary Healthcare
11%
Research Personnel
11%
Palliative Care
11%
France
11%
Histones
11%
Astrocytoma
11%
Oligodendroglioma
10%
Brain
9%
Neoplasm Metastasis
9%
Delivery of Health Care
9%
Systematic Reviews
8%
Recurrence
8%
Pediatrics
8%
Pharmaceutical Preparations
8%
Magnetic Resonance Imaging
7%
Chromosomes, Human, Pair 1
7%
Multivariate Analysis
7%
Population
6%
Mutation
6%